Results 211 to 220 of about 27,265 (285)

Case Report: CYLD cutaneous syndrome with malignant transformation to spiradenocarcinoma: cooperative effects of CYLD truncation and an MSH2 clamp-domain variant in an Ecuadorian patient. [PDF]

Front Med (Lausanne)
Reyes-Silva C, Jaramillo-Koupermann G, Quishpe M, Pacheco R, Burgos-Tapia S, Zambrano AK, Cabrera-Andrade A.   +6 more
europepmc   +1 more source

Histone H2A Deubiquitinase MYSM1 [PDF]

, 2020
openaire   +1 more source

Roles of Deubiquitinases OTUD3 and OTUD5 in Inflammatory Bowel Diseases. [PDF]

Int J Mol Sci
Watanabe T, Kudo M.
europepmc   +1 more source

Regulation of endothelial Notch signalling by deubiquitinases [PDF]

, 2017
Lim, Radiance
core  

Roles of ubiquitin‑specific peptidase 22 in cellular fate: From embryonic survival to tissue repair, inflammation and metabolism (Review). [PDF]

Int J Mol Med
Xiang JN, Zhou CY, Zhao YD, Xu X, Ling SB.   +4 more
europepmc   +1 more source

Ubiquitination in macrophage plasticity: from inflammatory to immunometabolic pathways. [PDF]

Front Immunol
Liu J, Paolino M.
europepmc   +1 more source

Targeting mitochondrial deubiquitinase USP30 to induce mitophagy in heteroplasmic mitochondrial diseases. [PDF]

Pharmacol Rep
Pinho BR, Martins V, Chacko AR, Nogueira C, Duchen MR, Oliveira JMA.   +5 more
europepmc   +1 more source

Ubiquitinating a Deubiquitinase

Journal of Biological Chemistry, 2007
openaire   +1 more source

Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway. [PDF]

J Cancer
Kuang S, Feng W, He S, Meng W, Yang C, Ning Y.   +5 more
europepmc   +1 more source

Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer

Cell Death and Differentiation, 2020
Jiawen Zhang, Yunfei Chen, Xianfei Chen, Wen Zhang, Linlin Zhao, Linjun Weng, H. Tian, Zhiqiang Wu, Xiao Tan, Xin Ge, Ping Wang, L. Fang   +11 more
semanticscholar   +1 more source